Imaging and nanomedicine for diagnosis and therapy in the central nervous system: Report of the eleventh annual blood-brain barrier disruption consortium meeting

American Journal of Neuroradiology

Volumn 27, Issue 3, 2006, Pages 715-721

  Muldoon, L L ^a   Tratnyek, P G ^a   Jacobs, P M ^e   Doolittle, N D ^a   Christoforidis, G A ^b   Frank, J A ^c   Lindau, M ^d   Lockman, P R ^f   Manninger, S P ⁱ   Qiang, Y ^g   Spence, A M ^h   Stupp, S I ^j   Zhang, M ^h   Neuwelt, Edward A ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d Department of Obstetrics Gynecology   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^g UNIVERSITY OF IDAHO   (United States)

^h UNIVERSITY OF WASHINGTON   (United States)

ⁱ NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

^j NORTHWESTERN UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

3' FLUOROTHYMIDINE; CAFFEINE; CARBON 11; CHLOROTOXIN; CLAUDIN 1; CONTRAST MEDIUM; CYTOTOXIN; FERUMOXYTOL; FLUORINE 18; FLUORODEOXYGLUCOSE F 18; GADOLINIUM; GELATINASE A; GLYCOPROTEIN P; IOPAMIDOL; IRON OXIDE; LEVODOPA; MACROGOL; OCCLUDIN; PACLITAXEL; PEPTIDE DERIVATIVE; PROTEINASE; RECOMBINANT CYTOTOXIN; RESERPINE; RNA; SUPERPARAMAGNETIC IRON OXIDE; THEOPHYLLINE; THYMIDINE; TOXIN; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNINDEXED DRUG;

ARTICLE; BLOOD BRAIN BARRIER; BRAIN CANCER; BRAIN DAMAGE; BRAIN NECROSIS; CANCER DIAGNOSIS; CENTRAL NERVOUS SYSTEM DISEASE; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; GLIOMA; HUMAN; MEDICAL SOCIETY; NANOMEDICINE; NANOTECHNOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIODIAGNOSIS; TUMOR DIAGNOSIS; UNITED STATES; CONFERENCE PAPER;

BLOOD-BRAIN BARRIER; CENTRAL NERVOUS SYSTEM DISEASES; DIAGNOSTIC IMAGING; HUMANS; NANOMEDICINE;

EID: 33745903890     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Ricci PE, Karis JP, Heiserman JE, et al. Differentiating recurrent tumor from radiation necrosis: time for re-evaluation of positron emission tomography? AJNR Am J Neuroradiol 1998;19:407-13
2. Delbeke D, Meyerowitz C, Lapidus RL, et al. Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET. Radiology 1995;195:47-52
3. Spence AM, Muzi M, Graham MM, et al. 2-[(18)F]Fluoro-2-deoxyglucose and glucose uptake in malignant gliomas before and after radiotherapy: correlation with outcome. Clin Cancer Res 2002;8:971-79
4. Degen JW, Walbridge S, Vortmeyer AO, et al. Safety and efficacy of convection-enhanced delivery of gemcitabine or carboplatin in a malignant glioma model in rats. J Neurosurg 2003;99:893-98
5. Parney IF, Kunwar S, McDermott M, et al. Neuroradiographic changes following convection-enhanced delivery of the recombinant cytotoxin interleukin 13-PE38QQR for recurrent malignant glioma. J Neurosurg 2005;102:267-75
6. Croteau D, Walbridge S, Morrison PF, et al. Real-time in vivo imaging of the convective distribution of a low-molecular-weight tracer. J Neurosurg 2005;102:90-97
7. Muldoon LL, Manninger S, Pinkston KE, et al. Imaging, distribution and toxicity of iron oxide magnetic resonance agents in rat brain and intracerebral tumor. Neurosurgery 2005;57:785-95
8. Muldoon LL, Varallyay P, Kraemer DF, et al. Trafficking of superparamagnetic iron oxide particles (Combidex) from brain to lymph nodes in the rat. Neuropathol Appl Neurobiol 2004;30:70-79
9. Christoforidis GA, Kangarlu A, Abduljalil AM, et al. Susceptibility-based imaging of glioblastoma microvascularity at 8 T: correlation of MR imaging and postmortem pathology. AJNR Am J Neuroradiol 2004;25:756-60
10. Dashner RA, Chakeres DW, Kangarlu A, et al. MR imaging visualization of the cerebral microvasculature: a comparison of live and postmortem studies at 8 T. AJNR Am J Neuroradiol 2003;24:1881-84
11. Neuwelt EA, Várallyay P, Bagó AG, et al. Imaging of iron oxide nanoparticles by MR and light microscopy in patients with malignant brain tumors. Neuropathol Appl Neurobiol 2004;30:456-71
12. Varallyay P, Nesbit G, Muldoon LL, et al. Comparison of two superparamagnetic viral-sized iron oxide particles ferumoxides and ferumoxtran-10 with a gadolinium chelate in imaging intracranial tumors. AJNR Am J Neuroradiol 2002;23:510-19
13. Manninger SP, Muldoon LL, Nesbit G, et al. An exploratory study of ferumoxtran-10 nanoparticles as a blood brain-barrier imaging agent targeting phagocytic cells in CNS inflammatory lesions. AJNR Am J Neuroradiol 2005;26:2290-300
14. Frank JA, Anderson SA, Kalish H, et al. Methods for magnetically labeling of stem cells and other cells for detection by in vivo magnetic resonance imaging. Cytotherapy 2004;6:621-25
15. Arbab AS, Yocum GT, Kalish H, et al. Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. Blood 2004;104:1217-23. Epub 2004 Apr 20
16. Anderson SA, Shukaliak-Quandt J, Jordan EK, et al. Trafficking of magnetically labeled encephalitogenic T-cells in the EAE mouse model by cellular magnetic resonance imaging. Ann Neurol 2004;55:654-59
17. Anderson SA, Glod J, Arbab AS, et al. Non-invasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model. Blood 2005;105:420-25
18. Zhang Z, Jiang Q, Jiang F, et al. In vivo magnetic resonance imaging tracks adult neural progenitor cell targeting brain tumor. Neuroimage 2004;23:281-87
19. Allport JR, Weissleder R. In vivo imaging of gene and cell therapies. Exp Hematol 2001;29:1237-46
20. Lockman PR, Mumper RJ, Khan MA, et al. Nanoparticle technology for drug delivery across the blood-brain barrier. Drug Dev Ind Pharm 2002;28:1-13
21. Qiang Y, Antony J, Marino MG, et al. Synthesis of core-shell nanoclusters with high magnetic moment for biomedical applications. IEEE Transactions on Magnetics 2004;40:3538-40
22. Kohler N, Fryxell GE, Zhang M. A bifunctional poly(ethylene glycol) silane immobilized on metallic oxide-based nanoparticles for conjugation with cell targeting agents. J Am Chem Soc 2004;126:7206-11
23. Zhang Y, Kohler N, Zhang M. Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake. Biomaterials 2002;23:1553-61
24. Deshane J, Garner CC, Sontheimer H. Chlorotoxin inhibits glioma cell invasion via matrix metalloproteinase-2. J Biol Chem 2003;278:4135-44. Epub 2002 Nov 25
25. Weissleder R, Ntziachristos V. Shedding light onto live molecular targets. Nat Med 2003;9:123-28
26. Lockman PR, Koziara JM, Roder KE, et al. In vivo and in vitro assessment of baseline blood-brain barrier parameters in the presence of novel nanoparticles. Pharm Res 2003;20:705-13
27. Koziara JM, Lockman PR, Allen DD, et al. In situ blood-brain barrier transport of nanoparticles. Pharm Res 2003;20:1772-78
28. Koziara JM, Lockman PR, Allen DD, et al. Paclitaxel nanoparticles for the potential treatment of brain tumors. J Control Release 2004;99:259-69
29. Dernick G, Alvarez De Toledo G, Lindau M. Exocytosis of single chromaffin granules in cell-free inside-out membrane patches. Nat Cell Biol 2003;5:358-62
30. Gong LW, Hafez I, Alvarez De Toledo G, et al. Secretory vesicles membrane area is regulated in tandem with quantal size in chromaffin cells. J Neurosci 2003;23:7917-21
31. An SJ, Almers W. Tracking SNARE complex formation in live endocrine cells. Science 2004;306:1042-46
32. Dias AF, Dernick G, Valero V, et al. An electrochemical detector array to study cell biology on the nanoscale. Nanotechnology 2002;13:285-89
33. Behanna HA, Donners J, Gordon AC, et al. Coassembly of amphiphiles with opposite peptide polarities into nanofibers. J Am Chem Soc 2005;127:1193-200
34. Guler MO, Soukasene S, Hulvat JF, et al. Presentation and recognition of biotin on nanofibers formed by branched peptide amphiphiles. Nano Lett 2005;5:249-52
35. Hartgerink JD, Beniash E, Stupp SI. Peptide-amphiphile nanofibers: a versatile scaffold for the preparation of self-assembling materials. Proc Natl Acad Sci U S A 2002;99:5133-38
36. Silva GA, Czeisler C, Niece KL, et al. Selective differentiation of neural progenitor cells by high-epitope density nanofibers. Science 2004;303:1352-55
37. Zhu J, Wu X, Zhang HL. Adult neural stem cell therapy: expansion in vitro, tracking in vivo and clinical transplantation. Curr Drug Targets 2005;6:97-110